EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Buccal Administration of a Zika Virus Vaccine Utilizing 3D-Printed Oral Dissolving Films in a Mouse Model

Sarthak Shah, Parth Patel, Amarae Ferguson, Priyal Bagwe iD, Akanksha Kale iD, Emmanuel Adediran, Revanth Singh, Tanisha Arte, Dedeepya Pasupuleti, Mohammad N Uddin, Martin D'Souza

Vaccines · 28.06.2024 · 12 (7) · 720

DOI: 10.3390/vaccines12070720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 28.06.2024. Verfasst von Sarthak Shah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the years, research regarding the Zika virus has been steadily increasing. Early immunization for ZIKV is a priority for preventing complications such as microencephaly and Guillain–Barré syndrome (GBS). Unlike traditional vaccination approaches, oral dissolving films (ODFs) or mucoadhesive film technology is an emerging, exciting concept that can be used in the field of pharmaceuticals for vaccine design and formulation development. This attractive and novel method can help patients who suffer from dysphagia as a complication of a disease or syndrome. In this study, we investigated a microparticulate Zika vaccine administered via the buccal route with the help of thin films or oral dissolving films (ODFs) with a prime dose and two booster doses two weeks apart. In vitro, the ODFs displayed excellent physiochemical properties, indicating that the films were good carriers for vaccine microparticles and biocompatible with the buccal mucosa. In vivo results revealed robust humoral (IgG, subtypes IgG1 and IgG2a) and T-cell responses (CD4+/CD8+) for ZIKV-specific immunity. Both the Zika MP vaccine and the adjuvanted Zika MP vaccine affected memory (CD45R/CD27) and intracellular cytokine (TNF-α and IL-6) expression. In this study, ZIKV vaccination via the buccal route with the aid of ODFs demonstrated great promise for the development of pain-free vaccines for infectious diseases.

Schlagwörter

Stichwörter der Autor:innen

Guillain–Barré syndrome (GBS)Zikabuccalmicroparticlesmucoadhesive filmnanotechnologyorally dissolving films (ODFs)

Autor:innen und Institutionen

  • Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.

ORCID-Profile: Priyal Bagwe, Akanksha Kale

Zitieren

APA

Shah, S., Patel, P., Ferguson, A., Bagwe, P., Kale, A., Adediran, E., Singh, R., Arte, T., Pasupuleti, D., Uddin, M. N., & D'Souza, M. (2024). Buccal Administration of a Zika Virus Vaccine Utilizing 3D-Printed Oral Dissolving Films in a Mouse Model. Vaccines, 12(7), 720. https://doi.org/10.3390/vaccines12070720

Vancouver

Shah S, Patel P, Ferguson A, Bagwe P, Kale A, Adediran E, et al. Buccal Administration of a Zika Virus Vaccine Utilizing 3D-Printed Oral Dissolving Films in a Mouse Model. Vaccines. 2024;12(7):720. doi:10.3390/vaccines12070720

BibTeX
@article{Shah2024,
  author = {Shah, Sarthak and Patel, Parth and Ferguson, Amarae and Bagwe, Priyal and Kale, Akanksha and Adediran, Emmanuel and Singh, Revanth and Arte, Tanisha and Pasupuleti, Dedeepya and Uddin, Mohammad N and D'Souza, Martin},
  title = {Buccal Administration of a Zika Virus Vaccine Utilizing 3D-Printed Oral Dissolving Films in a Mouse Model},
  journal = {Vaccines},
  year = {2024},
  volume = {12},
  number = {7},
  pages = {720},
  doi = {10.3390/vaccines12070720}
}
Kostenlos starten →